Intercellular adhesion molecule 2 (ICAM2), a transmembrane glycoprotein, can promote the NEDD4L-mediated ubiquitination and degradation of RDX, thereby inhibiting the tumorigenicity and metastasis of gastric cancer (Tang et al., 2023). Here, ICAM2 is linked to gastric cancer.